These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 29413167)

  • 1. Sympathetic Activation in Essential Hypertension: Understanding the Toxic Trifecta.
    Esler M
    Heart Lung Circ; 2018 Mar; 27(3):271-273. PubMed ID: 29413167
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of elevated heart rate as a sympathetic nervous system biomarker in essential hypertension.
    Esler M; Lambert G; Esler D; Ika Sari C; Guo L; Jennings G
    J Hypertens; 2020 Aug; 38(8):1488-1495. PubMed ID: 32195820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noradrenaline spillover and microneurography measurements in patients with primary hypertension.
    Jennings GL
    J Hypertens Suppl; 1998 Aug; 16(3):S35-8. PubMed ID: 9747908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sympathetic nerve activity and neurotransmitter release in humans: translation from pathophysiology into clinical practice.
    Esler M; Lambert G; Brunner-La Rocca HP; Vaddadi G; Kaye D
    Acta Physiol Scand; 2003 Mar; 177(3):275-84. PubMed ID: 12608997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating sympathetic activity in human hypertension.
    Mancia G; Grassi G; Parati G; Daffonchio A
    J Hypertens Suppl; 1993 Dec; 11(5):S13-9. PubMed ID: 8158309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent postural vasovagal syncope: sympathetic nervous system phenotypes.
    Vaddadi G; Guo L; Esler M; Socratous F; Schlaich M; Chopra R; Eikelis N; Lambert G; Trauer T; Lambert E
    Circ Arrhythm Electrophysiol; 2011 Oct; 4(5):711-8. PubMed ID: 21844155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differing pattern of sympathoexcitation in normal-weight and obesity-related hypertension.
    Lambert E; Straznicky N; Schlaich M; Esler M; Dawood T; Hotchkin E; Lambert G
    Hypertension; 2007 Nov; 50(5):862-8. PubMed ID: 17909120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sympathetic activity and presynaptic adrenoceptor function in patients with longstanding essential hypertension.
    Chang PC; Kriek E; van Brummelen P
    J Hypertens; 1994 Feb; 12(2):179-90. PubMed ID: 8021470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The sympathetic nervous system in the pathogenesis of hypertension.
    Rahn KH; Barenbrock M; Hausberg M
    J Hypertens Suppl; 1999 Aug; 17(3):S11-4. PubMed ID: 10489093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High blood pressure management: potential benefits of I1 agents.
    Esler M
    J Hypertens Suppl; 1998 Aug; 16(3):S19-24. PubMed ID: 9747906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of inspiratory muscle training with load compared with sham training on blood pressure in individuals with hypertension: study protocol of a double-blind randomized clinical trial.
    Posser SR; Callegaro CC; Beltrami-Moreira M; Moreira LB
    Trials; 2016 Aug; 17():382. PubMed ID: 27484507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and Angiotensin neuromodulation.
    Schlaich MP; Lambert E; Kaye DM; Krozowski Z; Campbell DJ; Lambert G; Hastings J; Aggarwal A; Esler MD
    Hypertension; 2004 Feb; 43(2):169-75. PubMed ID: 14610101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives.
    Grassi G
    Hypertension; 2009 Oct; 54(4):690-7. PubMed ID: 19720958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation in the effects of the angiotensin II receptor blocker class on autonomic function.
    Esler M
    J Hypertens Suppl; 2002 Jun; 20(5):S13-9. PubMed ID: 12184059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sympathetic activity, blood pressure variability and end organ damage in hypertension.
    Mancia G; Di Rienzo M; Parati G; Grassi G
    J Hum Hypertens; 1997 Aug; 11 Suppl 1():S3-8. PubMed ID: 9321734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy.
    Schlaich MP; Kaye DM; Lambert E; Sommerville M; Socratous F; Esler MD
    Circulation; 2003 Aug; 108(5):560-5. PubMed ID: 12847071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early and late sympathetic activation in hypertension.
    Mancia G; Di Rienzo M; Giannattasio C; Parati G; Grassi G
    Scand Cardiovasc J Suppl; 1998; 47():9-14. PubMed ID: 9540128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sympathetic and baroreflex cardiovascular control in hypertension-related left ventricular dysfunction.
    Grassi G; Seravalle G; Quarti-Trevano F; Dell'Oro R; Arenare F; Spaziani D; Mancia G
    Hypertension; 2009 Feb; 53(2):205-9. PubMed ID: 19124679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The sympathetic nervous system in human hypertension.
    Mancia G; Grassi G; Parati G; Zanchetti A
    Acta Physiol Scand Suppl; 1997; 640():117-21. PubMed ID: 9401621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of gender on the sympathetic nerve hyperactivity of essential hypertension.
    Hogarth AJ; Mackintosh AF; Mary DA
    J Hum Hypertens; 2007 Mar; 21(3):239-45. PubMed ID: 17167522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.